Studying ADHD In Youth Of Different Races
The research in the article looked at childhood ADHD in underrepresented minorities, reviewing controversy around evaluation, diagnosis, and obstacles faced by families, ending with recommendations for assessment and treatment.
Auriga Laboratories Obtains Rights To Market And Sell A New Product Indicated For The Treatment Of ADHD
Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company, announced today the signing of a license agreement with Outlook Pharmaceuticals, Inc., pursuant to which Auriga will have the exclusive rights to market and sell a new product indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the United States.
VYVANSE Demonstrates Significant Efficacy For Treatment Of ADHD For Up To 12 Hours After Administration
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that Biological Psychiatry published the results of a study showing VYVANSE™ (lisdexamfetamine dimesylate), the first prodrug stimulant for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), provided significant efficacy in children for up to 12 hours.
Nonstimulant Medication Is A Safe And Effective Alternative For ADHD Treatment In Children With Fragile X Syndrome
Fragile X syndrome (FXS) is the most common hereditary form of mental retardation. Many children with FXS also suffer from attention deficit and/or hyperactivity disorder (ADHD), which complicates social relationships at home and at school.
ADHD Stimulant Treatment Has No Effect On Risk Of Future Substance Abuse
A new study finds that the use of stimulant drugs to treat children with ADHD has no effect on their future risk of substance abuse. The report, which will appear in the American Journal of Psychiatry and has been issued online, assessed more than 100 young men 10 years after they had been diagnosed with ADHD and is the most methologically rigorous analysis of any potential relationship between stimulant treatment and drug abuse.
Studies Review Smoking Among College Freshmen And Tobacco Use By Adolescents With ADHD
A supplemental issue of Nicotine and Tobacco Research published yesterday includes a variety of key findings on the smoking habits of college freshmen; nicotine dependence; the use of tobacco by individuals with attention- deficit/ hyperactivity disorder, depression and anxiety;
Young Hyperactive Girls More Likely To Have Serious Problems As Adults
Young girls who are hyperactive are more likely to get hooked on smoking, under-perform in school or jobs and gravitate towards mentally abusive relationships as adults, according to a joint study by researchers from the Universit~A de Montr~A al and the University College London (UCL).
Methylphenidate Can Have Sleep Benefits In Adults With ADHD
Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP.
Probable Cause Identified Of Age Differences In Stimulant Response
In young children, psychostimulants relieve symptoms of Attention Deficit Disorder, yet in adolescents and adults, those same medications can cause euphoria and are often abused.What is behind these differing drug responses?Temple University scientists have identified a potential molecular mechanism, the neurotrophin system comprised of brain-derived neurotrophic factor (BDNF) and its receptor TrkB, as the cause of age differences in stimulant response.
New Study Finds Working Memory Training Produces Lasting Improvements In Kids With Attention Deficits
Stephen Bozylinski, Ph.D, a clinical psychologist and director of the ADHD Clinic of Southern California, released findings from a new open label study demonstrating the effectiveness of Cogmed Working Memory Training to sustainably improve attention and executive processing in children with ADHD.